Epigenetic Biomarkers Are Applicable for Risk Stratification in Myelodysplastic Syndromes

被引：1
|
作者：
Mies, Anna [1 ]
Bozic, Tanja [2 ]
Kramer, Michael [1 ]
Franzen, Julia [2 ]
Ehninger, Gerhard [1 ]
Bornhauser, Martin [1 ,3 ]
Platzbecker, Uwe [1 ,3 ]
Wagner, Wolfgang [2 ]
机构：
[1] Univ Hosp Carl Gustav Carus Dresden, Dept Internal Med 1, Dresden, Germany
[2] RWTH Aachen Med Sch, Helmholtz Inst Biomed Engn, Stem Cell Biol & Cellular Engn, Aachen, Germany
[3] German Canc Consortium, Heidelberg, Germany
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3194.3194
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3194
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes
    Yao, Chi-Yuan
    Lin, Chien-Chin
    Wang, Yu-Hung
    Kao, Chein-Jun
    Tsai, Cheng-Hong
    Hou, Hsin-An
    Tien, Hwei-Fang
    Hsu, Chia-Lang
    Chou, Wen-Chien
    BLOOD ADVANCES, 2024, 8 (10) : 2442 - 2454
  • [32] MOLECULAR PATHOGENESIS AND PROGNOSTIC STRATIFICATION OF MYELODYSPLASTIC SYNDROMES
    Cazzola, M.
    HAEMATOLOGICA, 2022, 107 : 1 - 2
  • [33] DNA Methylation Biomarkers in Myelodysplastic Syndromes
    Nguyen, V. T.
    Nalluri, S.
    Wang, M. X.
    LABORATORY INVESTIGATION, 2009, 89 : 279A - 279A
  • [34] DNA Methylation Biomarkers in Myelodysplastic Syndromes
    Nguyen, V. T.
    Nalluri, S.
    Wang, M. X.
    MODERN PATHOLOGY, 2009, 22 : 279A - 279A
  • [35] Somatic mutations and epigenetic abnormalities in myelodysplastic syndromes
    Itzykson, Raphael
    Kosmider, Olivier
    Fenaux, Pierre
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (04) : 355 - 364
  • [36] Current status of epigenetic treatment in myelodysplastic syndromes
    Andrea Kuendgen
    Michael Lübbert
    Annals of Hematology, 2008, 87 : 601 - 611
  • [37] Epigenetic regulation in myelodysplastic syndromes: implications for therapy
    Vigna, Ernesto
    Recchia, Anna Grazia
    Madeo, Antonio
    Gentile, Massimo
    Bossio, Sabrina
    Mazzone, Carla
    Lucia, Eugenio
    Morabito, Lucio
    Gigliotti, Vincenzo
    De Stefano, Laura
    Caruso, Nadia
    Servillo, Pasquale
    Franzese, Stefania
    Fimognari, Filippo
    Bisconte, Maria Grazia
    Gentile, Carlo
    Morabito, Fortunato
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (04) : 465 - 493
  • [38] Current status of epigenetic treatment in myelodysplastic syndromes
    Kuendgen, Andrea
    Luebbert, Michael
    ANNALS OF HEMATOLOGY, 2008, 87 (08) : 601 - 611
  • [39] Genetic and Epigenetic Drug Targets in Myelodysplastic Syndromes
    Stankov, Karmen
    Stankov, Suncica
    Katanic, Jasmina
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (01) : 135 - 169
  • [40] Myelodysplastic Syndromes: A Multidisciplinary Integrated Diagnostic Work-up for Patients' Risk Stratification
    Ciabatti, Elena
    Ferreri, Maria Immacolata
    Valetto, Angelo
    Guazzelli, Alice
    Bertini, Veronica
    Grassi, Susanna
    Guerrini, Francesca
    Azzara, Antonio
    Metelli, Maria Rita
    Petrini, Iacopo
    Simi, Paolo
    Petrini, Mario
    Galimberti, Sara
    BLOOD, 2014, 124 (21)
12345